Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer’s disease

@article{Sambamurti2002AdvancesIT,
  title={Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer’s disease},
  author={Kumar Sambamurti and Nigel H. Greig and Debomoy K. Lahiri},
  journal={NeuroMolecular Medicine},
  year={2002},
  volume={1},
  pages={1-31}
}

• Kumar Sambamurti, Nigel H. Greig, Debomoy K. Lahiri
• Published 2002 in NeuroMolecular Medicine
• DOI:10.1385/NMM:1:1:1

Alzheimer’s disease (AD) is a progressive senile dementia characterized by deposition of a 4 kDa peptide of 39–42 residues known as amyloid beta-peptide (Aβ) in the form of senile plaques and the microtubule associated protein tau as paired helical filaments. Genetic studies have identified mutations in the Aβ precursor protein (APP) as the key triggers for the pathogenesis of AD. Other genes such as presenilins 1 and 2 (PS1/2) and apolipoprotein E (APOE) also play a critical role in increased… CONTINUE READING

Save to Library

Create Alert

Cite

View on Springer